Skip to main content
logo
Novyra Pharmachem Limited (BOM:519353)
India flag India · Delayed Price · Currency is INR
10.67
0.00 (0.00%)
At close: Aug 21, 2026

Novyra Pharmachem Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
18.011.04--1.51.5
Revenue Growth
2208.33%---0%0%
Net Income
-53.86-53.74-0.64-1.590.120.03
Earnings Per Share
-8.88-8.49-0.10-0.260.020.01
EPS Growth
----241.88%-95.71%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Cash (Debt)
1.771.772.630.852.210.77
Net Cash Growth
--32.73%209.88%-61.62%188.85%-28.29%
Net Cash Per Share
0.290.280.420.140.360.12
Cash & Investments
1.771.772.630.852.210.77

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
--37.86-2.84-1.371.38-0.6
Free Cash Flow
--37.86-2.84-1.371.38-0.6
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Margin
-299.13%-5147.22%--17.38%-23.57%
Pretax Margin
-299.14%-5147.32%--21.79%2.67%
Profit Margin
-299.14%-5147.32%--7.71%2.26%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
----519.54855.13
PS Ratio
3.6988.87--40.0819.30